SCHEDULE 13D

Company

NovaBay Pharmaceuticals, Inc.

Filed

September 16, 2016

Accession Number

0001437749-16-038816

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →